Shares of Apollo Hospitals Enterprise Ltd. surged by 6.59%, trading at ₹7,427, following the company’s impressive Q2 financial performance. Apollo Hospitals reported a substantial 59% year-on-year increase in consolidated net profit, reaching ₹395.7 crore for the quarter ending September 2024, compared to ₹248.8 crore in the same period last year.
The company’s revenue for the quarter climbed to ₹5,589.3 crore, up from ₹4,846.9 crore in Q2 of the previous year, reflecting robust business growth. Additionally, Apollo Hospitals achieved an Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ₹815.5 crore, which represents a healthy margin of 14.16%.
This positive earnings report has not only boosted Apollo’s share price but also elevated its market capitalization significantly, reflecting strong investor confidence in the company’s future growth prospects.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.
